Let's talk medical research

ESG, short for “Environmental, Social, and Governance,” is a set of standards for a company’s operations that socially conscious investors use to screen potential investments. This year, Antidote is tackling the environmental piece of ESG head-on.

Is it possible to be creative in clinical trial advertising while following FDA guidelines, social media ad rules, and additional IRB constraints? You can create compelling ads without breaking the rules if you take the time to strategize.

We’re excited to share new ways that partners in our network are moving the research and advocacy fronts forward. BrightFocus Foundation funds exceptional scientific research worldwide to defeat Alzheimer’s disease, macular degeneration, and glaucoma. They recently started a live-streaming talk show, Brain Info Live, as part of their mission to provide expert information on Alzheimer’s disease ...

Two of the most critical components of any clinical trial recruitment campaign are patient-centricity and trust. Antidote has a robust Contact Center with personable and knowledgeable agents that walk patients through the prescreening process and answer any questions along the way. We spoke with our Contact Center Operations Manager, Andy Schulz, about why he joined the team, what his team’s ...

Clinical trials can’t move forward without volunteers. But, the barrier to entry for clinical trials can be inordinately high, starting with public information like a study page or a listing in a database. We share three tips for people who want to participate in a clinical trial, such as having your medical history handy, using a clinical trial search tool, and creating a list of questions to ...

People of color are largely unrepresented in clinical research studies. However, many factors, including biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background, can influence how an individual may react to certain drugs, medical devices, and treatment plans. We share three key ways to drive diversity in clinical trials, so that ...

Clinical trial project managers are at the heart of research. They keep studies running on schedule, help manage budgets, choose and liaise between vendors, report on results, enforce compliance, and fulfill other key duties.

When a clinical trial is in danger of not meeting its endpoints, sponsors may consider rescuing the research initiative by bringing a new set of vendors into the mix. With appropriate planning, sponsors can transition to a new team seamlessly, minimize any momentum lost, and ensure that the new vendors are set up for success.

Like clinical trials for medications, devices must go through various testing processes before they can be approved for patients. Medical device trials, however, are typically smaller in scale and require fewer phases.

With 80% of clinical trials failing to meet enrollment timelines and up to 50% of sites enrolling one or no patients at all, there are many opportunities to “rescue” studies. When timelines are at risk, data quality is suspect, and management practices are questionable, a new vendor can be brought in to rescue a study and get it back on track.